HNRNPC and adrenal cortex carcinoma: Subsequent analyses suggested a potential correlation between elevated HNRNPC expression and reduced disease-free survival (DFS) in ACC, KIRP, KIPAN, LIHC, Cervical Squamous Cell Carcinoma (CESC), and Mesothelioma (MESO) patients (Fig. 2C).